NeuroPace Inc cotiza a 13.00 USD y tiene una capitalización bursátil de $446M. En los últimos 12 meses ha facturado $99M con un margen de flujo de caja libre del -11.3%. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
NeuroPace, Inc. operates as a medical device company in the United States. The company develops RNS system, a brain-responsive neuromodulation system that delivers personalized, real-time treatment at the seizure source for treating drug-resistant focal epilepsy. Its RNS System includes RNS neurostimulator, cortical st…
| Periodo | 2026-11 | 2026-08 | 2026-08 | 2026-03 |
|---|---|---|---|---|
| Real | — | $-0.18 | — | $-0.08 |
| Estimado | $-0.09 | $-0.19 | $-0.19 | $-0.15 |
| Sorpresa | — | +5.3% | — | +46.7% |
| Métrica | NPCE | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | 77.2% | 57.0% | +20.2% |
| Operating Margin | -16.3% | -38.6% | +22.3% |
| Net Margin | -21.5% | -33.6% | +12.1% |
| FCF Margin | -11.3% | -13.9% | +2.5% |
| ROE | -112.8% | -40.4% | -72.4% |
| ROA | -20.3% | -32.0% | +11.7% |
| Current Ratio | 5.28 | 2.84 | +2.44 |
| Debt / Equity | 3.09 | 0.28 | +2.81 |